Connect with us

Featured Stocks

County Line Energy (OTC: CYLC): This Hidden Gem Grows More Than Just Weed

Published

on

OTC: CYLC

County Line Energy Corp. (OTC: CYLC) could be the next pot stock to hit the JACK POT as the company aggressively carves out a household name for itself in the legal marijuana arena!

Many slang words have evolved over the years for marijuana, but it doesn’t matter what you call it. 

What matters is that cannabis, Mary Jane, ganja, etc., has evolved into a colossal sector that is worth billions upon billions of dollars.

This is an industry that has created massive business opportunities and has provided health benefits to a slew of people who suffer from a range of disorders including depression, insomnia, pain, PTSD, and even serious diseases like cancer. 

There is no doubt that legal marijuana is a boom to the economy, bringing salvation to states that are now able to generate massive revenue from taxes. 

Colorado, one of the first states to legalize the drug, has money pouring in from its legal recreational marijuana sales. The state surpassed a whopping $1 billion in tax revenue this year since recreational use was legalized in 2014!

Support for legalizing the plant has also reached an all-time high in America according to the latest Gallup poll and every Democrat running for president in 2020 is now in favor of marijuana legislation on a federal level. Prohibition in America could be on its very last legs!

It has been estimated that 1/3rd of America’s marijuana is now grown inside according to motherjones.com. and this is what could help make County Line Energy Corp. (OTC: CYLC) one of the most opportunistic plays on Wall Street!

With its acquisition of Grow Box 5000, County Line Energy Corp. (OTC: CYLC) may quickly become the go to source for cannabis growing all over!

Through its wholly-owned operating subsidiary D5 Partners, Inc., County Line Energy Corp. (OTC: CYLC) is the developer and distributor of the Grow Box 5000 family of self-contained, fully automated, and expandable smart hydroponics systems for use in growing plants and vegetables. 

The company’s mission is to customize ecosystems that enable you to grow your own vegetables, hemp and cannabis in the most advanced way possible.

One in 3 households are now growing food — this the highest overall participation and spending levels that have been seen in a decade according to the company. 

Millennials represent a big chunk of this segment, moving from 8 million growers in 2008 to 13 million in 2013.

An exciting aspect about the company’s self-contained growing systems is that they could become a household name in cannabis cultivation in doors!

GROW BOX 5K was created with a focus on creating a platform that promotes indoor Cannabis production on all scales.

Cannabis cultivation today is a lot different than what it was decades ago where people cultivated the drug in secrecy. Hidden buildings, or deep forests were the only choices for many to grow marijuana.

Today people can grow it from their own homes and control their growing right from their smart phones. This is a high-tech world and cannabis growing can be simple and easy to do because of it.

The GROW BOX 5K is fully automated and can be controlled from your smartphone which means you can set it up and walk away. Multiple Grow Boxes can also be linked together and controlled from a single interface.

Product highlights include: Easy to use, saves users money, fully automated, and have the best technology and construction. 

Competitively priced starting at $1,499, the system features high quality 20″ x 20″ x 44″ stainless steel, aluminum, and high-grade plastics structure. It also come switch automatic temperature control, automatic LED lighting control, automatic watering/feeding control, and semi-automatic water refill and drain capability.

HEPA filters facilitate the intake of pest and bacteria-free fresh air and activated charcoal filters clean and exhaust scrubbed odorless air. The controlled systems are also Wi-fi enabled and feature camera capabilities to view and share your grow progress from any smartphone or PC.

The system is also easily upgradeable and expandable and available in multiple exterior finishes to match most any room decor.

“Grow Box 5000 represents the cumulative expertise of over 30 years of building highly complicated machines and products for consumers across the globe.  The Grow Box 5000 series incorporates decades of professional growing know-how into an attractive, yet powerful design, that’s fully automated and easy to use, from the comfort of your own home, and completely controlled from your computer or smartphone.”

Eric Dena, D5 Partners, Inc. CEO and Grow Box 5000 co-creator, has said:

“We are confident that many potential growers, particularly in the rapidly expanding regulated and legalized cannabis and medical marijuana space, will embrace this technology to automate and simplify their personal-scale operations.”

According to GreenCoastHydroponics.com, the GROW BOX 5k “is the most advanced Grow System” they have ever seen!

The company just recently gave the green light to the phase 2 development of the Grow Box 5000.

With Phase 1 complete, County Line Energy Corp. (OTC: CYLC) has decided to move to Phase 2, which includes fully automated systems for advanced growing and management prototypes.  

“We expect to deliver the fully automated machines 1st quarter 2020.  These systems will contain software to assist in controlling the environment of the GB5K to ensure the highest yields possible, regulating lighting, water, and atmospheric changes.”

The GB5K units can be custom skinned to integrate with any type of home décor. Further, it will be available in a variety of sized to ensure households of any size will have the most efficient outcome.

According to the Marijuana Business Factbook, retail sales of medical and recreational cannabis in the United States are on pace to eclipse $12 billion by the end of this year. This would be an increase of roughly 35% over 2018.

Retail sales could rise as high as $30 billion by 2023!

It was a banner year in 2018 with investors pouring an amazing $10 billion into cannabis in North America.

There has been a tremendous amount of positive buzz surrounding the legal marijuana industry, especially with politician on board to decriminalize the plant. This has helped marijuana stocks witness supreme rallies in recent years.

When the Food and Drug Administration approves the first pharmaceutical drug made from cannabis, it says something. When Corona Beer’s owner makes a $4 billion bet on a marijuana firm called Canopy Growth it says something. 

When one marijuana company called Tilray Inc. sees its shares explode from under $60 to over $200 in just three weeks after making its debut in the market, it says something. 

When one analyst predicts that legal marijuana could soon become a bigger industry than soda, it says something.

One of the top marijuana analysts, Vivien Azer at Cowen, is also calling for total U.S. cannabis sales to hit $80 billion by 2030!

Although competitors exist in the market such as Leaf, Grobo, Trim, leaf, Home Grow Rooms/Tents, Aero Garden, and Miracle-Gro, D5 partners have competitive advantage over them on the basis of broader experience in global manufacturing with a very strong background in bringing commercial products to consumers. 

Moreover, the company does not need to rely on subcontractors and vendors to construct and design the products and most of the skills required are in-house.

Hemp is also said to have enormous environmental, economic, and commercial potential and growers could be looking at County Line Energy Corp. (OTC: CYLC) for their needs. The 2018 Farm Bill was passed last year, and it legalized the regulated production of hemp.

The 2018 National Gardening Survey found that an astonishing 15% of US households would grow marijuana at home if it was legal. 

A survey from Yahoo News and Marist College, has additionally illustrated just how mainstream marijuana has become. Nearly 55 million adults currently use the drug. Let’s face it, we are in a MARIJUANA REVOLUTION!

Over the years, research has yielded results that indicate marijuana may be beneficial in the treatment of many conditions including chronic pain, drug addiction, anxiety, PTSD, neurological disorders, and cancer. 

What do all of these things say? That marijuana is here to stay and that pot stocks could be heading even higher. 

Marijuana is not a taboo topic anymore and companies are generating stellar profits from the plant. Canadian marijuana producer Aurora Cannabis recently reported that it saw a 349% year-over-year increase in revenue!

It was only last October that County Line Energy Corp. (OTC: CYLC) launched public pre-orders for its flagship Grow Box 5000 self-contained smart hydroponics systems.

The company looks determined to become recognized in the legal cannabis space and has recently announced the formation and launch of a marketing and social media team. 

These are still the very early stages for the company and current share prices could be screaming opportunity… This is one pot stock that could soon be unstoppable as traders get it on their radar!

County Line Energy Corp. (OTC: CYLC) may be one of the next stocks to explode as Wall Street learns about the Grow Box 5000 and its potential in the monstrous legal marijuana sector!

DISCLAIMER
DISCLAIMER – THIS NEWSLETTER IS A PAID ADVERTISEMENT, NOT A RECOMMENDATION NOR AN OFFER TO BUY OR SELL SECURITIES. THIS NEWSLETTER IS OWNED, OPERATED AND EDITED BY ARCHANGEL MEDIA CONSULTING, LLC.  ANY WORDING FOUND IN THIS E-MAIL OR DISCLAIMER REFERENCING TO “I” OR “WE” OR “OUR” OR “ARCHANGEL MEDIA” REFERS TO ARCHANGEL MEDIA CONSULTING, LLC.  OUR BUSINESS MODEL IS TO BE FINANCIALLY COMPENSATED TO MARKET AND PROMOTE SMALL PUBLIC COMPANIES.  BY READING OUR NEWSLETTER AND OUR WEBSITE YOU AGREE TO THE TERMS OF OUR DISCLAIMER, WHICH ARE SUBJECT TO CHANGE AT ANY TIME. WE ARE NOT REGISTERED OR LICENSED IN ANY JURISDICTION WHATSOEVER TO PROVIDE INVESTMENT ADVICE OR ANYTHING OF AN ADVISORY OR CONSULTANCY NATURE AND ARE THEREFORE ARE UNQUALIFIED TO GIVE INVESTMENT RECOMMENDATIONS. ALWAYS DO YOUR OWN RESEARCH AND CONSULT WITH A LICENSED INVESTMENT PROFESSIONAL BEFORE INVESTING. THIS COMMUNICATION IS NEVER TO BE USED AS THE BASIS OF MAKING INVESTMENT DECISIONS AND IS FOR ENTERTAINMENT PURPOSES ONLY. AT MOST, THIS COMMUNICATION SHOULD SERVE ONLY AS A STARTING POINT TO DO YOUR OWN RESEARCH AND CONSULT WITH A LICENSED PROFESSIONAL REGARDING THE COMPANIES PROFILED AND DISCUSSED. CONDUCT YOUR OWN RESEARCH. COMPANIES WITH A LOW PRICE PER SHARE ARE SPECULATIVE AND CARRY A HIGH DEGREE OF RISK, SO ONLY INVEST WHAT YOU CAN AFFORD TO LOSE. BY USING OUR SERVICE YOU AGREE NOT TO HOLD OUR SITE, ITS EDITOR’S, OWNERS, OR STAFF LIABLE FOR ANY DAMAGES, FINANCIAL OR OTHERWISE, THAT MAY OCCUR DUE TO ANY ACTION YOU MAY TAKE BASED ON THE INFORMATION CONTAINED WITHIN OUR NEWSLETTERS OR ON OUR WEBSITE. 
WE DO NOT ADVISE ANY READER TO TAKE ANY SPECIFIC ACTION. LOSSES CAN BE LARGER THAN EXPECTED IF THE COMPANY EXPERIENCES ANY PROBLEMS WITH LIQUIDITY OR WIDE SPREADS. OUR WEBSITE AND NEWSLETTER ARE FOR ENTERTAINMENT PURPOSES ONLY. NEVER INVEST PURELY BASED ON OUR ALERTS. GAINS MENTIONED IN OUR NEWSLETTER AND ON OUR WEBSITE MAY BE BASED ON END-OF-DAY OR INTRADAY DATA. THIS PUBLICATION AND THEIR OWNERS AND AFFILIATES MAY HOLD POSITIONS IN THE SECURITIES MENTIONED IN OUR ALERTS, WHICH WE MAY SELL AT ANY TIME WITHOUT NOTICE TO OUR SUBSCRIBERS, WHICH MAY HAVE A NEGATIVE IMPACT ON SHARE PRICES. ARCHANGEL MEDIA’S BUSINESS MODEL IS TO RECEIVE FINANCIAL COMPENSATION TO PROMOTE PUBLIC COMPANIES.  WE HAVE BEEN COMPENSATED A FEE OF SEVENTY-FIVE THOUSAND US DOLLARS VIA BANK WIRE FOR A ONE-MONTH CYLC AWARENESS CAMPAIGN BY A THIRD PARTY, BLUE DIAMOND EQUITIES, LLC. PREVIOUSLY, WE WERE COMPENSATED TWO HUNDRED THOUSAND DOLLARS BY A THIRD PARTY, BLUE DIAMOND EQUITIES, LLC. THIS COMPENSATION IS A MAJOR CONFLICT OF INTEREST IN OUR ABILITY TO BE UNBIASED REGARDING. THEREFORE, THIS COMMUNICATION SHOULD BE VIEWED AS A COMMERCIAL ADVERTISEMENT ONLY. WE HAVE NOT INVESTIGATED THE BACKGROUND OF THE HIRING THIRD PARTY OR PARTIES.  ANY NON-COMPENSATED ALERTS ARE PURELY FOR THE PURPOSE OF EXPANDING OUR DATABASE FOR THE BENEFIT OF OUR FUTURE FINANCIALLY COMPENSATED INVESTOR RELATIONS EFFORTS. FREQUENTLY COMPANIES PROFILED IN OUR ALERTS MAY EXPERIENCE A LARGE INCREASE IN VOLUME AND SHARE PRICE DURING THE COURSE OF INVESTOR RELATIONS MARKETING, WHICH MAY END AS SOON AS THE INVESTOR RELATIONS MARKETING CEASES. THE INVESTOR RELATIONS MARKETING MAY BE AS BRIEF AS ONE DAY, AFTER WHICH A LARGE DECREASE IN VOLUME AND SHARE PRICE IS LIKELY TO OCCUR. OUR EMAILS MAY CONTAIN FORWARD-LOOKING STATEMENTS, WHICH ARE NOT GUARANTEED TO MATERIALIZE DUE TO A VARIETY OF FACTORS.
WE DO NOT GUARANTEE THE TIMELINESS, ACCURACY, OR COMPLETENESS OF THE INFORMATION ON OUR SITE OR IN OUR NEWSLETTERS. THE INFORMATION IN OUR EMAIL NEWSLETTERS AND ON OUR WEBSITE IS BELIEVED TO BE ACCURATE AND CORRECT, BUT HAS NOT BEEN INDEPENDENTLY VERIFIED AND IS NOT GUARANTEED TO BE CORRECT. THE INFORMATION IS COLLECTED FROM PUBLIC SOURCES, SUCH AS THE PROFILED COMPANY’S WEBSITE AND PRESS RELEASES, BUT IS NOT RESEARCHED OR VERIFIED IN ANY WAY WHATSOEVER TO ENSURE THE PUBLICLY AVAILABLE INFORMATION IS CORRECT. FURTHERMORE, ARCHANGEL MEDIA OFTEN EMPLOYS INDEPENDENT CONTRACTOR WRITERS WHO MAY MAKE ERRORS WHEN RESEARCHING INFORMATION AND PREPARING THESE COMMUNICATIONS REGARDING PROFILED COMPANIES. INDEPENDENT WRITERS’ WORKS ARE DOUBLE-CHECKED AND VERIFIED BEFORE PUBLICATION, BUT IT IS CERTAINLY POSSIBLE FOR ERRORS OR OMISSIONS TO TAKE PLACE DURING EDITING OF INDEPENDENT CONTRACTOR WRITER’S COMMUNICATIONS REGARDING THE PROFILED COMPANY(S). YOU SHOULD ASSUME ALL THE INFORMATION IN ALL OF OUR COMMUNICATIONS IS INCORRECT UNTIL YOU PERSONALLY VERIFY THE INFORMATION, AND AGAIN ARE ENCOURAGED TO NEVER INVEST BASED ON THE INFORMATION CONTAINED IN OUR WRITTEN COMMUNICATIONS. THE INFORMATION IN OUR DISCLAIMERS IS SUBJECT TO CHANGE AT ANY TIME WITHOUT NOTICE.
Continue Reading
1 Comment

1 Comment

  1. john zajac

    November 5, 2019 at 5:27 am

    Any large crop grown in this country will make money. This crop for industrial purposes will make a great deal of money. Large scale hydroponics will increase production of this crop.

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured Stocks

Why Lexaria Bioscience Corp (OTCMKTS:LXRP) Is A Comeback Play

Published

on

Lexaria Bioscience

Lexaria Bioscience Corp (OTCMKTS:LXRP) brightest days lie ahead. The sentiments shared by Chief Executive Officer, Chris Bunka, are slowly coming to fruition, going by recent price action activity. After a steep pullback in 2019, the stock has once again started climbing higher, as investors react to milestones achieved in 2019 that affirm long-term prospects.

Lexaria Bioscience Catalysts and Price Analysis

A confirmation that the global innovator in drug delivery systems achieved almost everything it set out to accomplish in 2019 continues to strengthen market sentiments. The inking of strategic partnerships with Fortune 500 style companies is another development that the management continues to tout.

Likewise, Lexaria Bioscience succeeded in getting its DehydraTECH technology to market, consequently creating an avenue for generating long-term value. The company’s Intellectual Property strategy has also started to pay dividends, affirming what is at stake going forward. Reports that the company is already experiencing an increase in revenues is another catalyst that continues to shore the stock’s sentiments and prospects in the markets.

Lexaria Bioscience has already started bottoming out from all-time lows in what appears to be the development of a positive trend. A 10% plus rally from one-year lows continue to fuel optimism that the stock has clocked a bottom and due for a correction higher.

Standing in the way of the emerging uptrend is the $0.50 mark, which is the immediate short-term resistance level. A rally followed by a close above the…

Continue Reading

Featured Stocks

Helix TCS Stock (OTCMKTS:HLIX): A Fundamentally Attractive Investment

Published

on

Helix TCS stock

Helix TCS Stock (OTCMKTS:HLIX) is turning out to be an interesting pick after a steep pullback in 2019. The stock appears to be trading at a big discount going by the solid fundamentals that support a bounce back from current lows. If you are looking for a company seeing plenty of opportunities on the horizon then Helix TCS stock fits the bill.

Helix TCS Stock Catalysts and Price Analysis

The company is currently ranked at number 32 on the Deloitte Technology 500 fastest growing companies. The impressive rating stems from the company reporting impressive financial results depicted by an 80% increase in revenue and a 39% increase in cash flow from operations.

Likewise, the company has moved to strengthen its prospects in the hemp business by launching the nation’s first hemp tracking system. Similarly, the company has inked a strategic partnership with Alt Thirty Six for the launch of digital payments targeting thousands of dispensaries across the U.S

Reports that Helix TCS BioTrack traceability stem processed over $11 million transactions in the first week of recreational sales attest to what could turn out to be a break out year for the company and its technology.

It thus does not come as a surprise that the company’s stock has started to pick up some steam after a roller coaster 2019. A 10% plus rally since the start of the year affirms renewed investor interest in response to the wave of…

Continue Reading

Featured Stocks

Why OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Is A Promising Stock In 2020

Published

on

OWC Pharmaceutical Research

In 2020, investors are looking for cannabis stocks that can deliver excellent returns following a disappointing 2019, which saw many pot stocks crash to multiyear lows. OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) stands out as a promising cannabis stock to own in 2020.

About OWC Pharmaceutical Research

The cannabis stock universe is vast, so for investors who may have just come across OWC Pharmaceutical for the first time an introduction of the company is in order.

OWC Pharmaceutical is an Israel-based cannabis research company. It is focused on research and development of cannabis-based medical products. The company’s work currently includes development of cannabis-based treatments for a variety of diseases and disorders such as multiple myeloma, psoriasis and fibromyalgia.

Moreover, OWC Pharmaceutical provides consulting services to both government and private entities in the field of medical cannabis programs.

OWC Pharmaceutical Research exited 2019 on a high note

While 2019 ended up being one of the toughest year for cannabis stocks, OWC Pharmaceutical had strong finish to the year. The stock gained 35% on December 31. Before that, the stock rose 65% on December 30. The back-to-back gains in the final days of 2019 helped OWC Pharmaceutical cut its losses for the year but also signaled improving investor sentiment on the stock heading into the new year.

OWC Pharmaceutical finished 2019 at $0.089, having pulled from a low of $0.0045 at the beginning of December.

What…

Continue Reading

MJ Stocks